Skip to main content
Have a personal or library account? Click to login

References

  1. Lane JC, Weaver J, Kostka K, et al. Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: A multinational, network cohort and self-controlled case series study. MedRxiv. DOI: 10.1101/2020.04.08.20054551
  2. Al-Khatib SM, Allen LaPointe NM, Kramer JM, Califf RM. What Clinicians Should Know about the QT Interval. J Am Med Assoc. 2003; 21207. DOI: 10.1001/jama.289.16.2120
  3. Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ. Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19). Mayo Clin Proc. 2020. DOI: 10.1016/j.mayocp.2020.03.024
  4. Sagie A, Larson MG, Goldberg RJ, Bengtson JR, Levy D. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). Am J Cardiol. 1992; 70(7): 797801. DOI: 10.1016/0002-9149(92)90562-D
  5. Lanjewar P, Pathak V, Lokhandwala Y. Issues in QT interval measurement. Indian Pacing Electrophysiol J. 2004; 4(4): 15661.
  6. Haugaa KH, Bos JM, Tarrell RF, Morlan BW, Caraballo PJ, Ackerman MJ. Institution-wide QT alert system identifies patients with a high risk of mortality. Mayo Clin Proc. 2013; 88(4): 31525. DOI: 10.1016/j.mayocp.2013.01.013
  7. Drew BJ, Ackerman MJ, Funk M, et al. Prevention of Torsade de Pointes in Hospital Settings. A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation Endorsed by the American Association of Critical-Care Nurses and the International Society. J Am Coll Cardiol. 2010; 93447. DOI: 10.1016/j.jacc.2010.01.001
  8. Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM. Azithromycin and the risk of cardiovascular death. N Engl J Med. 2012; 366(20): 188190. DOI: 10.1056/NEJMoa1003833
  9. Chen CY, Wang FL, Lin CC. Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia. Clin Toxicol. 2006; 44(2): 1735. DOI: 10.1080/15563650500514558
  10. Reed MJ, Grubb NR, Lang CC, et al. Multi-centre Randomised Controlled Trial of a Smartphone-based Event Recorder Alongside Standard Care Versus Standard Care for Patients Presenting to the Emergency Department with Palpitations and Pre-syncope: The IPED (Investigation of Palpitations in the ED) study: study protocol for a randomised controlled trial. EClinicalMedicine. 2019; 8: 3746. DOI: 10.1016/j.eclinm.2019.02.005
  11. Abudan AA, Isath A, Ryan JD, et al. Safety and compatibility of smart device heart rhythm monitoring in patients with cardiovascular implantable electronic devices. J Cardiovasc Electrophysiol. 2019; 30(9): 16029. DOI: 10.1111/jce.14024
  12. Benezet-Mazuecos J, García-Talavera CS, Rubio JM. Smart devices for a smart detection of atrial fibrillation. J Thorac Dis. 2018; S38247. DOI: 10.21037/jtd.2018.08.138
  13. Koltowski L, Balsam P, Glłowczynska R, et al. Kardia Mobile applicability in clinical practice: A comparison of Kardia Mobile and standard 12-lead electrocardiogram records in 100 consecutive patients of a tertiary cardiovascular care center. Cardiol J. 2013. DOI: 10.5603/CJ.a2019.0001
  14. Garabelli P, Stavrakis S, Albert M, et al. Comparison of QT Interval Readings in Normal Sinus Rhythm Between a Smartphone Heart Monitor and a 12-Lead ECG for Healthy Volunteers and Inpatients Receiving Sotalol or Dofetilide. J Cardiovasc Electrophysiol. 2016; 27(7): 82732. DOI: 10.1111/jce.12976
  15. Cheung CC, Davies B, Gibbs K, Laksman ZW, Krahn AD. Multi-lead QT screening is necessary for QT measurement: Implications for management of patients in the COVID-19 era. JACC Clin Electrophysiol. 2020. DOI: 10.1016/j.jacep.2020.04.001
  16. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020; 382(13): 1199207. DOI: 10.1056/NEJMoa2001316
  17. Cheng HY, Jian SW, Liu DP, Ng TC, Huang WT, Lin HH. Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods before and after Symptom Onset. JAMA Intern Med. 2020. DOI: 10.1001/jamainternmed.2020.2020
  18. Saleh M, Gabriels J, Chang D, et al. The Effect of Chloroquine, Hydroxychloroquine and Azithromycin on the Corrected QT Interval in Patients with SARS-CoV-2 Infection. Circ Arrhythm Electrophysiol. 2020. DOI: 10.1161/CIRCEP.120.008662
  19. Chang D, Saleh M, Gabriels J, et al. Inpatient use of ambulatory telemetry monitors for COVID-19 patients treated with hydroxychloroquine and/or azithromycin. J Am Coll Cardiol. 2020; 75(23): 29923. DOI: 10.1016/j.jacc.2020.04.032
DOI: https://doi.org/10.5334/gh.916 | Journal eISSN: 2211-8179
Language: English
Submitted on: Sep 4, 2020
Accepted on: Mar 26, 2021
Published on: Jun 8, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Carlos Minguito-Carazo, Julio Echarte-Morales, Tomás Benito-González, Samuel del Castillo-García, Miguel Rodríguez-Santamarta, Enrique Sánchez-Muñoz, Clea González Maniega, Rubén García-Bergel, Paula Menéndez-Suárez, Silvia Prieto-González, Carmen Palacios-Echavarren, Javier Borrego-Rodríguez, Guisela Flores-Vergara, Ignacio Iglesias-Garriz, Felipe Fernández-Vázquez, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.